IP Library Granted Patent US 8,802,847
Granted Patent B2
US 8,802,847 · App. 13/684,670 · Granted Aug 12, 2014

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,847
App. No.
13/684,670
Granted
Aug 12, 2014
Kind
B2
Abstract

The present application relates to a novel and efficient process for preparing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders. More particularly, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for preparation of the compound of the formula (I) which serves for production of medicaments, for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.

Claims (10)

1. A process of preparing a compound of formula (I), comprising using the compound of formula (VI)

to prepare a compound of formula (I)

wherein the compound of formula (I) is optionally converted with an appropriate (i) solvent and/or (ii) acid or base to the solvate, salt and/or solvate of the salt thereof.

2. A process of preparing a compound of formula (I)

by converting the compound of the formula (VI) to the compound of the formula (VII)

reacting the compound of formula (VII) in an inert solvent in the presence of a suitable base with the compound of the formula (VIIIa)

to give the compound of the formula (VIII)

and reducing the compound of formula (VIII) in an inert solvent in the presence of a suitable reducing agent to give the compound (IX)

and reacting the compound of formula (IX) with methyl chloroformate or with dimethyl dicarbonate in the presence of a suitable base with or without solvent to give the compound of the formula (I), and

optionally, converting the resulting compound of formula (I) with the appropriate (i) solvent and/or (ii) acid or base to the solvate, salt and/or solvate of the salt thereof.

Assignments (9)
CHANGE OF PATENTEE ADDRESS Recorded Feb 8, 2021
From: ADVERIO PHARMA GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 056907/0570 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL 046254 FRAME 0444. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 3, 2018
From: FEY, PETER
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 047191/0117 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046254 FRAME: 0444. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 19, 2018
From: FEY, PETER
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 047531/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 046790/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 046790/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 046254/0444 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 14217644 PREVIOUSLY RECORDED AT REEL: 034577 FRAME: 0443. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 21, 2015
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 034839/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2014
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 034577/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2014
From: FEY, PETER, DR.
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 031971/0864 →